Quarterly report · Q3
2533.TEDINET S100PEZ2
Period2022-01-01 → 2022-09-30
Filed2022-11-04
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥58.0bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥78.6bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥56.8bn | 2021-01-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | −¥869m | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥952m | 2021-01-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | −¥799m | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥993m | 2021-01-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥909m | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥278m | 2021-01-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.4bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥299m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥206m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.5bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥188m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥52.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥52.3bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥49.5bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥30.2bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.3bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥22.0bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥22.1bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥631m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥990m | at 2021-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-22.73 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.21 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.03 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.48 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.91 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-09-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-09-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-09-30 | ¥11m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥2m |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥381m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥51.9bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥51.9bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥1.1bn |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥286m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥286m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥151m |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥273m |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥57.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥57.9bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥2m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | −¥880m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-09-30 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-09-30 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-09-30 | ¥9m |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-09-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-09-30 | −¥1m |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥505m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥51.0bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥51.0bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥1m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥318m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥265m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥265m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥139m |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.8bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.8bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | segment profit | 2021-01-01 → 2021-09-30 | −¥20m |
| —segment total | revenue | 2021-01-01 → 2021-09-30 | ¥56.7bn |
| —segment total | revenue external | 2021-01-01 → 2021-09-30 | ¥56.7bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥1m |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥943m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 421
| Item | Context | Value | Unit |
|---|---|---|---|
| Intangible assets | Prior1YearInstant | 298000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 551000000 | JPY |
| Investment securities | Prior1YearInstant | 1404000000 | JPY |
| Investment securities | CurrentQuarterInstant | 1472000000 | JPY |
| Deferred tax assets | Prior1YearInstant | 891000000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 380000000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 17000000 | JPY |
| Net defined benefit asset | CurrentQuarterInstant | 22000000 | JPY |
| Other ioa | Prior1YearInstant | 313000000 | JPY |
| Other ioa | CurrentQuarterInstant | 358000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -5000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -5000000 | JPY |
| Investments and other assets | Prior1YearInstant | 2622000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 2228000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 26684000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 28636000000 | JPY |
| Assets | Prior1YearInstant | 52280000000 | JPY |
| Assets | CurrentQuarterInstant | 52534000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 4699000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 4861000000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 1624000000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 1367000000 | JPY |
| Short term loans payable | Prior1YearInstant | 3700000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 8800000000 | JPY |
| Accounts payable other | Prior1YearInstant | 4400000000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 3726000000 | JPY |
| Accrued alcohol tax | Prior1YearInstant | 8726000000 | JPY |
| Accrued alcohol tax | CurrentQuarterInstant | 4941000000 | JPY |
| Income taxes payable | Prior1YearInstant | 147000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 77000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 60000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 319000000 | JPY |
| Provision for directors bonuses | Prior1YearInstant | 17000000 | JPY |
| Provision for directors bonuses | CurrentQuarterInstant | 2000000 | JPY |
| Provision for shareholder benefit program cl | Prior1YearInstant | 18000000 | JPY |
| Provision for shareholder benefit program cl | CurrentQuarterInstant | - | JPY |
| Notes payable facilities | Prior1YearInstant | 159000000 | JPY |
| Notes payable facilities | CurrentQuarterInstant | 39000000 | JPY |
| Electronically recorded obligations facilities cl | Prior1YearInstant | 76000000 | JPY |
| Electronically recorded obligations facilities cl | CurrentQuarterInstant | 37000000 | JPY |
| Other cl | Prior1YearInstant | 1720000000 | JPY |
| Other cl | CurrentQuarterInstant | 658000000 | JPY |
| Current liabilities | Prior1YearInstant | 25350000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 24832000000 | JPY |
| Long term loans payable | Prior1YearInstant | - | JPY |
| Long term loans payable | CurrentQuarterInstant | 2400000000 | JPY |
| Long term deposits received | Prior1YearInstant | 3140000000 | JPY |
| Long term deposits received | CurrentQuarterInstant | 3152000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 164000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 245000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |